Company Overview and News
PRESIDENT Rodrigo R. Duterte on Tuesday witnessed the signing of 21 business agreements in Jerusalem between companies from the Philippines and Israel, Malacañang said, including a number of defense and security deals with Israeli makers of sophisticated surveillance and intelligence products.
Of all the buzzwords saturating the tech industry today, perhaps no other budding system is as veiled as blockchain. Essentially a distributed digital ledger, blockchain has become synonymous with its most popular application, cryptocurrencies like Bitcoin, and so has taken on much of its notoriety.
2018-06-28 bworldonline - 1
THE Labor department said it expects more workers to be given regular status soon after it inspects companies it earlier warned about employment practices that amount to illegal contractualization.
JBFCF CNPF JFC JBFCY
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CNPF RZLLY RCB
SUBIC BAY — Seychelles’ Nick Baldwin and Australia’s Liz Blatchford emerged as the top finishers of the Century Tuna Ironman Philippines 2018, the very first full-distance triathlon race in the country.
TOP and serious triathletes from at least 47 countries test their skills and will in the first full Ironman event in the Philippines on Sunday, June 3, in Subic, Zambales.
SINGAPORE — Of all the buzzwords saturating the tech industry today, perhaps no other budding system is as veiled as blockchain. Essentially a distributed digital ledger, blockchain has become synonymous with its most popular application, cryptocurrencies like Bitcoin, and so has taken on much of its notoriety.
The First Metro group rolled out on Wednesday a new mutual fund that allows long-term investors to bet on the Philippine consumer growth story by investing in a pool of companies based on MSCI-derived index.
MER GTCAP GTCXY SVTMF CNPF GTMEY BDOUY CEBUY SM RBLAY SECB BDOUF SMIVY JBFCF MPCFF PHSXY GTMEF PSE SPHXF SPHZF CEB GLOPA MSCI UVRBF AYAAF PSKXF MPCIY AYAAY JBFCY UVRBY GLOPP SMPH BDO GLO RLC CEBUF MPI SPHXY SYBJF JFC URC ALI
London’s venerable Financial Times (FT) recently released its first-ever “FT 1000 High-Growth Companies Asia-Pacific” list — with 26 Filipino firms making the grade, all of which are listed on the Philippine Stock Exchange except for one.
JGSMY CNPF JGS ATI SGI CEBUY TUGS ACR SSI JBFCF MWP PHSXY H2O LNSTY PSE MWIDE CEB AISNY JGSHF CIC PSKXF JBFCY PRGLY PGOLD MBC PGCMF CROWN TECH STI CEBUF SPC JFC PERC
2018-04-04 business.inquirer.net - 1
The country’s leading canned food producer Century Pacific Food Inc (CNPF) booked a 4-percent drop in net profit last year to P2.55 billion as the uptick in cost of raw materials relative to cyclical lows gnawed on margins.
PSKXF CNPF PHSXY PSE
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...